Research chemicals 25I-NBOMe explained: what this potent psychedelic is, why it's high risk, its Schedule I status in the US, and how labs detect it.
25I-NBOMe is a synthetic psychedelic research chemical in the NBOMe family and a potent derivative of the phenethylamine 2C-I. It acts mainly as a serotonin 5-HT2A receptor agonist and is active at microgram doses, which gives it one of the narrowest safety margins of any compound sold as a psychedelic. 25I-NBOMe is not approved for human use, is not a medicine, and is classified as a Schedule I controlled substance in the United States.
What Is 25I-NBOMe?
25I-NBOMe stands for 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine. The NBOMe tag refers to an N-benzyl methoxy group added to the 2C-I molecule, a structural change that sharply increases potency at the 5-HT2A receptor.
The compound was first described in the scientific literature in 2003 and began appearing in recreational markets around 2010. It is most often encountered as a liquid applied to blotter paper, as a loose powder, or pressed into tablets.
Because it is frequently laid on the same blotter paper used for LSD, 25I-NBOMe has been widely mis-sold as LSD. 25I-NBOMe is a phenethylamine, not a tryptamine supplement or a naturally occurring plant compound, and it is chemically unrelated to LSD.
Why 25I-NBOMe Is Considered High Risk
Safety concerns around 25I-NBOMe are not theoretical. Poison centers, public health agencies, and forensic laboratories have documented severe reactions and deaths linked to NBOMe compounds since they first appeared on the market.
- Microgram potency. Active amounts are measured in micrograms, far below what a typical consumer scale can resolve. A small weighing error produces a very large change in dose.
- Narrow margin between effects and toxicity. Reported adverse effects include agitation, seizures, severe vasoconstriction, hyperthermia, and rhabdomyolysis.
- Serotonergic interaction risk. Combining 25I-NBOMe with SSRIs, MAOIs, tramadol, triptans, or other serotonergic drugs is associated with serotonin syndrome risk.
- No quality control. Material sold on blotter is rarely tested for identity or dose, and counterfeit products may contain a different NBOMe, a different drug entirely, or nothing at all.
- No clinical framework. There is no accepted dosing standard, no supervised protocol, and no antidote for 25I-NBOMe.
There is no established safe dose of 25I-NBOMe. Serious outcomes are often reported at amounts that would look unremarkable on a small square of paper, which is why harm-reduction organizations place NBOMe compounds in a distinctly high-risk category.
25I-NBOMe Compared With LSD and 2C-I
25I-NBOMe is often discussed alongside classic psychedelics, but the practical differences matter. The table below compares reported potency, chemical class, and federal legal status.
| Compound | Chemical class | Primary receptor target | Reported potency | US legal status |
|---|---|---|---|---|
| 25I-NBOMe | Substituted phenethylamine (NBOMe) | 5-HT2A agonist | Microgram range | Schedule I |
| LSD | Ergoline (lysergamide) | 5-HT2A and other serotonin receptors | Microgram range | Schedule I |
| 2C-I | Substituted phenethylamine | 5-HT2A agonist | Milligram range | Schedule I |
The key takeaway is that 2C-I is active in the milligram range while 25I-NBOMe is active many times lower than that. That gap is why a mis-weighed dose of an NBOMe compound is far more likely to cause a medical emergency than a mis-weighed dose of a classic phenethylamine.
Legal Status of 25I-NBOMe in the United States
25I-NBOMe is a Schedule I controlled substance under the federal Controlled Substances Act. Schedule I means the DEA has determined the drug has no currently accepted medical use and a high potential for abuse. Many US states also prohibit NBOMe compounds separately under their own controlled substances laws.
A research chemical label does not create a legal exemption. Selling, possessing, or importing 25I-NBOMe for human consumption is illegal in the United States, and the not-for-human-consumption wording on many vendor listings is a disclaimer rather than a legal shield.
Vendors in this space often operate through sites advertising research chemicals and peptides for sale, and a toronto research chemicals address on a product page says nothing about whether the material is legal, what it contains, or how it was manufactured.
How 25I-NBOMe Is Detected in Laboratories
Forensic and clinical toxicology labs identify 25I-NBOMe using liquid chromatography-mass spectrometry (LC-MS), gas chromatography-mass spectrometry (GC-MS), and nuclear magnetic resonance spectroscopy. Certified reference standards for NBOMe compounds are sold to accredited laboratories for calibration and method validation.
Labs that maintain standards for research chemicals 5-meo-dmt and other controlled tryptamines often use the same instrument workflows, since both compound classes ionize well under common LC-MS conditions. Detection matters because 25I-NBOMe is regularly found in samples that users believe are LSD.
Vendor branding such as maxim research chemicals does not indicate independent purity testing. Reliable analytical chemistry depends on certified reference materials and documented chain of custody, not marketing language.
Safety Guidance and Where to Get Help
If someone has taken an unknown blotter or powder and develops confusion, seizures, chest pain, overheating, or severe agitation, treat it as a medical emergency. In the United States, Poison Control can be reached at 1-800-222-1222, and emergency services should be called for severe symptoms.
Because 25I-NBOMe can appear in products sold as something else, there is no reliable way to know what a mystery blotter contains without laboratory testing. Anyone with questions about drug interactions or personal health risk should speak with a physician, pharmacist, or licensed clinician.
Readers researching the topic for academic, forensic, or journalistic purposes can find peer-reviewed safety data through PubMed, the DEA, and the European Monitoring Centre for Drugs and Drug Addiction.
Frequently Asked Questions
Is 25I-NBOMe the same thing as LSD?
No. 25I-NBOMe is a phenethylamine in the NBOMe class, while LSD is an ergoline. The two are often confused because 25I-NBOMe is frequently applied to the same blotter paper used for LSD and sold under that name, but they are different molecules with very different risk profiles.
Is 25I-NBOMe legal in the United States?
No. 25I-NBOMe is a Schedule I controlled substance under the federal Controlled Substances Act, meaning the DEA considers it to have no accepted medical use and a high potential for abuse. Many states also ban NBOMe compounds under their own laws.
How dangerous is 25I-NBOMe compared with other psychedelics?
Public health agencies and poison centers treat NBOMe compounds as unusually dangerous because they are active at microgram doses with a narrow margin between effects and toxicity. Reported serious effects include seizures, severe vasoconstriction, hyperthermia, and death, and there is no established safe dose or medical antidote.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.